Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 133Brain Neoplasms 129Prostatic Neoplasms 108Neoplasm Metastasis 88Lung Neoplasms 74Carcinoma, Hepatocellular 71Pancreatic Neoplasms 69Breast Neoplasms 50Melanoma 44Carcinoma, Renal Cell 36Neoplasms 34Colorectal Neoplasms 26Squamous Cell Carcinoma of Head and Neck 25Glioblastoma 24Liver Neoplasms 20Head and Neck Neoplasms 17Small Cell Lung Carcinoma 15Sarcoma 13Kidney Neoplasms 13Glioma 12Urinary Bladder Neoplasms 10Recurrence 9Gliosarcoma 8Ovarian Neoplasms 7Central Nervous System Neoplasms 7Adenocarcinoma of Lung 7Adenocarcinoma 7Radiation Injuries 6Prostate Cancer Metastatic 6Neuroma, Acoustic 6

Interventions

sintilimab 1lenvatinib 1Radiosurgery 1Oxaliplatin 1Mitomycin 1Gemcitabine 1Cryosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Metastasis × Radiosurgery × Clear all
NCT00914615 2021-10-06

Stereotactic Body Radiation Therapy (SBRT) in Liver Metastasis (COLD 3)

University Health Network, Toronto

Phase 2 Completed
35 enrolled

Liver Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡